Communiqués

21/08/24 Practices and pathology providers – prohibited practices and the ‘Red Book': know your obligations AQ
15/12/23 ACCC opposes Australian Clinical Labs' proposed acquisition of Healius AQ
13/11/23 Medical practices and pathology providers – Prohibited practices and the 'Red Book': know your obligations AQ
20/03/23 No Enthusiasm To Combine ACL & Healius AQ
01/02/23 Agilex - Stephen McIntyre Joins Agilex Biolabs as CEO AQ
22/09/22 CN Diagnostics Partners with Grupo Fleury to Bring Pioneering Blood Tests to Brazil for Advancing Brain Health AQ
30/08/22 C2N Diagnostics and Healius Ltd Announce Partnership to Bring PrecivityAD™ and Related Brain Health Biomarkers to Patients in Australia BU
05/07/22 Healius : Application for quotation of securities - HLS PU
16/06/22 Healius : Update - Notification of buy-back - HLS PU
14/06/22 Healius : Update - Notification of buy-back - HLS PU
09/06/22 Healius : Update - Notification of buy-back - HLS PU
07/06/22 Healius : Update - Notification of buy-back - HLS PU
02/06/22 Healius : Update - Notification of buy-back - HLS PU
30/05/22 Healius : Update - Notification of buy-back - HLS PU
20/05/22 Healius : Strategy Day Presentation PU
02/05/22 Healius : Update - Notification of buy-back - HLS PU
29/04/22 Healius : Update - Notification of buy-back - HLS PU
27/04/22 Healius : Update - Notification of buy-back - HLS PU
19/04/22 Healius : Update - Notification of buy-back - HLS PU
14/04/22 Healius : Update - Notification of buy-back - HLS PU
11/04/22 Healius : Update - Notification of buy-back - HLS PU
07/04/22 Healius : Update - Notification of buy-back - HLS PU
04/04/22 Healius : Update - Notification of buy-back - HLS PU
31/03/22 Healius : Notification regarding unquoted securities - HLS PU
24/02/22 Healius : Application for quotation of securities - HLS PU
Aucun résultat pour cette recherche
-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT